Last reviewed · How we verify
paroxetine + aerobic exercise
Paroxetine increases serotonin availability in the brain while aerobic exercise enhances neuroplasticity and mood regulation through multiple physiological pathways.
Paroxetine increases serotonin availability in the brain while aerobic exercise enhances neuroplasticity and mood regulation through multiple physiological pathways. Used for Major depressive disorder, Generalized anxiety disorder.
At a glance
| Generic name | paroxetine + aerobic exercise |
|---|---|
| Sponsor | University of Göttingen |
| Drug class | SSRI + behavioral intervention |
| Target | Serotonin transporter (SERT) |
| Modality | Small molecule |
| Therapeutic area | Psychiatry / Mental Health |
| Phase | FDA-approved |
Mechanism of action
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that blocks serotonin reuptake at the synaptic cleft, increasing serotonergic neurotransmission. Aerobic exercise complements this by increasing brain-derived neurotrophic factor (BDNF), improving cardiovascular function, and promoting endogenous neurochemical changes that enhance antidepressant efficacy. The combination leverages both pharmacological and behavioral mechanisms to treat depression.
Approved indications
- Major depressive disorder
- Generalized anxiety disorder
Common side effects
- Nausea
- Sexual dysfunction
- Headache
- Insomnia or somnolence
- Muscle soreness (exercise-related)
Key clinical trials
- Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study) (NA)
- Physical EXercise as an Adjunct Treatment for Depression (NA)
- Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- paroxetine + aerobic exercise CI brief — competitive landscape report
- paroxetine + aerobic exercise updates RSS · CI watch RSS
- University of Göttingen portfolio CI